Using the 2 Stage Free Cash Flow to Equity, Apyx Medical fair value estimate is US$5.54. Current share price of US$3.35 suggests Apyx Medical is potentially 40% unde ...
Using the 2 Stage Free Cash Flow to Equity, Babcock & Wilcox Enterprises fair value estimate is US$9.71 Babcock & Wilcox Enterprises' US$5.15 share price signals that it might be 47% undervalued ...